Avalanche Biotechnologies Inc (NASDAQ:AAVL)‘s stock had its “buy” rating reiterated by Piper Jaffray in a report issued on Thursday, Analyst Ratings.Net reports. They presently have a $15.00 target price on the stock. Piper Jaffray’s price target suggests a potential upside of 172.73% from the company’s current price.
Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) belongs to Healthcare sector. Its weekly performance is 1.68%. On last trading day company shares ended up at $5.44. Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) distance from 50-day simple moving average (SMA50) is -6.28%.
Asterias Biotherapeutics, Inc. (NYSEMKT:AST) announced the appointment of pharmaceutical industry veteran Stephen L. Cartt as President and Chief Executive Officer and member of the Board of Directors. In addition, the Company announced the appointment of Don M. Bailey to its Board of Directors. Mr. Bailey, who previously served as President and Chief Executive Officer of Questcor Pharmaceuticals Inc. until its sale for $5.6 billion in 2014 to Mallinckrodt, plc, was named Chairman of the Board of Directors of Asterias.
Asterias Biotherapeutics, Inc. (NYSEMKT:AST) shares increased 18.88% in last trading session and ended the day at $5.10. AST Gross Margin is 92.50% and its return on assets is -25.40%. Asterias Biotherapeutics, Inc. (NYSEMKT:AST) quarterly performance is 7.37%.
On 16 February, Kaiser Aluminum Corporation (NASDAQ:KALU) reported a net loss of $237 million, or $13.76 loss per diluted share, for the year ended December 31, 2015, including the previously announced $307 million after-tax, non-run-rate charge associated with the termination of defined benefit accounting and the removal of the assets and liabilities related to the ongoing union voluntary employee beneficiary association (“Union VEBA”) from the Company’s consolidated balance sheet.
On 01 March, Kaiser Aluminum Corporation (NASDAQ:KALU) shares increased 2.70% and was closed at $78.68. KALU EPS growth in last 5 year was 8.63%. Kaiser Aluminum Corporation (NASDAQ:KALU) year to date (YTD) performance is -5.39%.
On 22 February, Rogers Corporation (NYSE:ROG) reported record fourth quarter net sales of $152.9 million, in line with the company’s previously announced guidance and a 3.5% increase from the net sales of $147.7 million for the 2014 fourth quarter. These results include $26.6 million of net sales from the acquired Arlon business. Net sales were unfavorably impacted by approximately $5.2 million of negative currency fluctuations primarily related to the decline in the value of the Euro.
Rogers Corporation (NYSE:ROG) ended the last trading day at $54.41. Company weekly volatility is calculated as 2.82% and price to cash ratio as 4.78. Rogers Corporation (NYSE:ROG) showed a weekly performance of 5.69%.
On 24 February, Chesapeake Energy Corporation (NYSE:CHK) provided financial and operational guidance for 2016 and reported financial and operational results for the 2015 full year and fourth quarter. Adjusted Ebitda was $2.385 billion for the 2015 full year, compared to $4.945 billion for the 2014 full year.
On 01 March, Chesapeake Energy Corporation (NYSE:CHK) shares advanced 5.75% and was closed at $2.76. CHK EPS growth in last 5 year was -61.40%. Chesapeake Energy Corporation (NYSE:CHK) year to date (YTD) performance is -38.67%.